Subscriber Only
In Race for Blood Cancer Therapy, a Chinese Biotech Firm Surges 500%
- GenScript has surged since June report of positive data
- CEO says go-ahead for human trials likely in second quarter

Source: Science Photo Library/TEVE GS/Brand X via Getty Images
Updated on